Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 46 of 537 for:    "Skin cancer"

In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00588315
Recruitment Status : Recruiting
First Posted : January 8, 2008
Last Update Posted : April 22, 2019
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
The purpose of this study is to investigate new non-invasive imaging techniques for the evaluation of skin lesions, as well as normal skin. Our primary goal is to collect and study these images of different skin lesions along with matching biopsy specimens. The long-term goal is to develop a technique that will improve the early detection of skin cancer and eliminate the need for many skin biopsies.

Condition or disease
Skin Cancer

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2500 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
Actual Study Start Date : November 1999
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Skin Cancer

Group/Cohort
1
skin lesions
2
normal skin



Primary Outcome Measures :
  1. The study is a descriptive one. No formal statistical testing of correlations will be performed. [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   10 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients of the Dermatology, Clinical Immunology Services, Pediatrics and Radiology Oncology departments that are determined to have a skin lesion with anticipated epidermal and superficial dermal histologic alterations amenable to visualization by surface confocal microscopy will be offered the opportunity to participate in the study.
Criteria

Inclusion Criteria:

  • Patients older than or equal to 10 years of age.
  • Patients with a skin lesion with anticipated epidermal and superficial dermal histologic alterations amenable to visualization by surface confocal microscopy.
  • Healthy volunteer subjects older than or equal to 10 years old.
  • Ability to give informed consent.

Exclusion Criteria:

  • Patients who are allergic to fluorescein sodium.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00588315


Contacts
Layout table for location contacts
Contact: Allan Halpern, MD 646-888-6013
Contact: Ashfaq Marghoob, MD 646-888-6017

Locations
Layout table for location information
United States, New Jersey
Memoral Sloan Kettering Basking Ridge Recruiting
Basking Ridge, New Jersey, United States
Contact: Allan Halpern, MD    646-888-6013      
United States, New York
Memorial Sloan Kettering Westchester Recruiting
Harrison, New York, United States, 10604
Contact: Allen Halpern, MD    646-888-6013      
Memorial Sloan Kettering Hauppauge Recruiting
Hauppauge, New York, United States, 11788
Contact: Allan Halpern, MD    646-888-6013      
Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States, 10065
Contact: Allan Halpern, MD    646-888-6013      
Contact: Ashfaq Marghoob, MD    646-888-6017      
Principal Investigator: Allan Halpern, MD         
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Investigators
Layout table for investigator information
Principal Investigator: Allan Halpern, MD Memorial Sloan Kettering Cancer Center

Additional Information:
Layout table for additonal information
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00588315     History of Changes
Other Study ID Numbers: 99-099
First Posted: January 8, 2008    Key Record Dates
Last Update Posted: April 22, 2019
Last Verified: April 2019

Additional relevant MeSH terms:
Layout table for MeSH terms
Neoplasms
Skin Neoplasms
Neoplasms by Site
Skin Diseases